Finance

Beta
Lists
PMN:NASDAQ
Promis Neurosciences Inc
$10.75
+2.09%
(+0.22) 1D
Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PMN...
Open
$10.66
High
$11.00
Low
$10.53
Mkt. cap
96.40M
Avg. vol.
18.38K
Volume
0.00
52-wk high
$39.75
52-wk low
$6.27
EPS
-$18.59
Beta
-0.15
Shares outstanding
8.97M
No. of employees
11
Open
$10.66
High
$11.00
Low
$10.53
Mkt. cap
96.40M
Avg. vol.
18.38K
Volume
0.00
52-wk high
$39.75
52-wk low
$6.27
EPS
-$18.59
Beta
-0.15
Shares outstanding
8.97M
No. of employees
11
News stories
From sources across the web
About Promis Neurosciences Inc
CEO-
Employees11
Founded2005
HeadquartersMississauga, Ontario, Canada
SectorBiotechnology
Websitepromisneurosciences.com
Analyst ratings
Based on 4 analysts giving stock ratings to PMN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PMN in the last 3 months.
Highest
Current $10.75
$40.00 (+272.09%)
Average
$32.00 (+197.67%)
Lowest
$18.00 (+67.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$18.00
+67.4%
06/25/2026
Unknown Analyst
Brookline Capital Markets
Buy
Initiated
$40.00
+272.1%
05/20/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$35.00
+225.6%
05/18/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$35.00
+225.6%
05/14/2026
Eddie Hickman
Guggenheim
Buy
Maintained
$35.00
+225.6%
02/05/2026
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
8.75M
9.80M
9.37M
-
Cost of revenue
8.75M
9.80M
9.37M
-
Research and development expenses
-
-
-
6.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.43M
1.95M
1.40M
1.67M
Operating expense
1.43M
1.95M
1.40M
8.64M
Total operating expenses
10.18M
11.75M
10.77M
8.64M
Operating income
-10.18M
-11.75M
-10.77M
-8.64M
Other non operating income
67.63K
170.31K
98.03K
400.52K
EBT including unusual items
-10.12M
-11.58M
-10.67M
-8.24M
EBT excluding unusual items
-10.12M
-11.58M
-10.67M
-8.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.12M
-11.58M
-10.67M
-8.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer